Sign in
Taking peopleNo phase

In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta

Key facts

Who runs it
Insel Gruppe AG, University Hospital Bern
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
98 people, planned
Started
14 Apr 2026
Expected to end
Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • resuscitative endovascular occlusion of the aorta (REBOA)
  • Advanced Cardiac Life Support (ACLS)
Record updated
21 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • patients suffering from in hospital cardiac arrest (IHCA), including patients with out of hospital cardiac arrest (OHCA) and return of spontaneous circulation (ROSC), transported to the emergency department, where they suffer a second arrest (IHCA)
  • successful placement of a femoral artery introducer sheath
  • any electrical cardiac activity seen in the initial rhythm analysis
  • ongoing effort of resuscitation as determined by study-independent resuscitation lead

Who cannot take part

  • hospital visitors suffering from cardiac arrest
  • traumatic cardiac arrest
  • known allergies to radiographic contrast agents
  • IHCA in the operating room, on intensive care unit or in the cardiac catheter laboratory
  • (presumed) age under 18 years
  • asystole seen in the initial rhythm analysis
  • known "do not resuscitate"-order
  • known or obvious pregnancy
  • known aortic pathologies that render cannulation impossible

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.

The 2 groups in the trial

  • Advanced Cardiac Life Support (ACLS) aloneExisting treatment, for comparison

    Advanced Cardiac Life Support (ACLS) as per the hospitals standard protocol, including advanced interventions such as extended cardio-pulmonary resuscitation (eCPR).

    Treatment: Advanced Cardiac Life Support (ACLS)

  • Advanced Cardiac Life Support (ACLS) plus REBOATreatment being tested

    Advanced Cardiac Life Support (ACLS) as per the hospitals standard protocol, including advanced interventions such as eCPR plus resuscitative balloon occlusion of the descending thoracic aorta (REBOA).

    Treatment: resuscitative endovascular occlusion of the aorta (REBOA) and Advanced Cardiac Life Support (ACLS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
Publications
Record updated
21 August 2026